Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine

Cancer Research

Volumn 57, Issue 5, 1997, Pages 948-955

  Tozer, Gillian M ^a   Prise, Vivien E ^a   Chaplin, David J ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; IMIDAZOLINE DERIVATIVE; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOSARCOMA; CONTROLLED STUDY; DRUG EFFECT; HEMODYNAMICS; MALE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR BLOOD FLOW; VASCULAR RESISTANCE;

ANIMALS; ARGININE; BENZOATES; BLOOD PRESSURE; ENZYME INHIBITORS; HEART RATE; IMIDAZOLES; MALE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NITRIC OXIDE SYNTHASE; NITROARGININE; RATS; REGIONAL BLOOD FLOW;

EID: 0031018039     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Sagar, S. M., Klassen, G. A., Barclay, K. D., and Aldrich, J, E. Tumor blood flow: measurement and manipulation for therapeutic gain, Cancer Treat. Rev,. 19: 299-349, 1993.
2. Dewhirst, M. W., Prescott, D. M, Clegg, S., Samulski, T. V., Page, R. L., Thrall, D. E., Leopold, K., Rosner, G., Acker, J. C, and Oleson, J. R. The use of hydralazine to manipulate tumor temperatures during hyperthermia. Int. J. Hyperthermia, 6: 971-983, 1990.
3. Chaplin, D. J., and Acker, B. The effect of hydralazine on the tumor cytoloxicity of the cell cytotoxin RSU-1069: evidence for therapeutic gain, Int. J. Radiat. Oncol. Biol. Phys., 13: 579-585, 1987.
4. Chaplin, D. J. Hydralazine-induced tumor hypoxia: a potential target for cancer chemotherapy, J. Natl. Cancer Inst., 81: 618-622, 1989.
5. Dewhirst, M. W., Madwed. D., Meyer, R. E., Ong, E. T., Kliteman, B., Rosner, G. L., and Dodge, R. Reduction in tumor blood flow in skin flap tumor after hydralazine is not due to a vascular steal phenomenon. Radiat. Oncol. Invest., I: 270-278, 1994.
6. Chaplin, D. J., and Trotter, M. J. Chemical modifiers of tumor blood flow, In: P. Vaupel and R. K. Jain (eds.), Tumor Blood Supply and Metabolic Environment, pp. 65-85, Stuttgart, New York: Gustav Fischer Verlag, 1991.
7. Horsman, M. R., Christensen, K. L., and Overgaard, J. Relationship between the hydralazine-induced changes in murine tumor blood flow supply and mouse blood pressure. Int. J. Radiat. Oncol. Biol. Phys., 22: 455-458, 1992.
8. Peterson, H-I. Modification of tumor blood flow-a review. Int. J. Radiat. Biol., 60: 201-210, 1991.
9. Buttery, L. D. K., Springall, D. R., Andrade, S. P., Riveros-Moreno, V., Hart, I., Piper, P. J., and Polak, J. M. Induction of nitric oxide synthase in neo-vasculature of experimental tumors in mice. J. Pathol., 171: 311-319, 1993.
10. Chhatwal, V. J, S., Ngoi, S. S., Chan, S. T. F., Chia, Y. W., and Moochhala, S. M. Aberrant expression of nitric oxide synthase in human polyps, ncoplastic colonie mucosa and surrounding peritumoral normal mucosa, Carcinogenesis (Lond), 15: 2081-2085, 1994.
11. Cobbs, C. S., Brenman, J. E., Aldape, K. D., Bredt, D. S., and Israel. M. A. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res., 55: 727-730, 1995.
12. Thomson, L. L., Lawton, F. G., Knowles, R. G., Beesley, J. E., Riveros-Moreno, V., and Moncada, S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res., 54: 1352-1354, 1994.
13. Thomson, L, L., Miles, D. W., Happerfield, L., Bobrow, L, G., Knowles, R. G., and Moncada, S. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer, 72: 41-44, 1995.
14. Andrade, S. P., Hart, I. R., and Piper, P. J. Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature. Br J. Pharmacol., 107: 1092-1095, 1992.
15. Wood, P., Stratford, I. J., Adams, G. E., Szabó, C., Thiemermann, C., and Vane. J. R. Modification of energy metabolism and radiation response of a murine tumor by changes in nitric oxide availability. Biochem. Biophys. Res. Commun., 192: 505-510, 1993.
16. G-nitro-L-arginine. Cancer Res., 54: 6458-6463, 1994.
17. Wood, P. J., Sansom, J. M., Stratford, I. J., Adams, G. E., Szabó, C., Thiemermann, C., and Vane. J. R. Modification of metabolism of transplantable and spontaneous murine tumors by the nitric oxide synthase inhibitor. nitro-L-arginine. Int. J. Radial. Oncol. Biol. Phys., 29: 443-447, 1994.
18. Meyer, R. E., Shan, S., DeAngelo, J., Dodge, R. K., Bonaventura, J., Ong, E. T., and Dewhirst, M. W. Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma. Br. J. Cancer, 71: 1169-1174, 1995.
19. Rees, D. D., Palmer. R. M. J., Schulz, R., Hodson, H. F., and Moncada, S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol., 101: 746-752. 1990.
20. Maeda, H., Akaike, T., Yoshida, M., and Suga, M. Multiple functions of nitric oxide in pathophysiology and microbiology: analysis by a new nitric oxide scavenger, J. Leukocyte Biol., 56: 588-592, 1994.
21. Yoshida, M., Akaike, T., Wada, Y. K. S., Ikeda, K., Ueda, S., and Maeda, H. Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity. Biochem, Biophys. Res. Commun., 202: 923-930, 1994.
22. Maeda, H-, Noguchi, Y., Sato, K., and Akaike, T, Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn. J. Cancer Res., 85: 331-334, 1994.
23. Tozer, G. M., and Shaffi, K. M. Modification of tumor blood flow using the hypertensive agent, angiotensin II. Br. J. Cancer, 67: 981-988, 1993.
24. Tozer, G. M., and Morris, C. Blood flow and blood volume in a transplanted rat fibrosarcoma: comparison with various normal tissues. Radiother. Oncol., 17: 153-166, 1990.
25. Kety, S. S. Theory of blood tissue exchange and its application to measurements of blood fiow. Methods Med. Res., 8: 223-227, 1960.
26. Tozer, G, M., Shaffi, K. M., Prise, V. E., and Cunningham. V. J. Characterisation of tumor blood flow using a "tissue-isolated" preparation. Br. J. Cancer. 70: 1040-1046, 1994.
27. Tozer, G. M., Prise, V. E., Everett, S. A., Stratford, M. R. L., Dennis, M. F., Wordsworth, S,. and Chaplin, D. J. Effect of modification of nitric oxide levels on tumor vascular tone. In: S. Moncada, J. Stamler, S. Gross, and E. A. Higgs (eds.), The Biology of Nitric Oxide, p. 215. London: Portland Press. 1996.
28. Gardiner, S. M., Kemp, P. A., March, J. E., and Bennett, T. Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br. J. Pharmacol., 116: 2005-2016, 1995.
29. Tozer, G. M., Prise, V. E., and Bell, K. M. The influence of nitric oxide on tumor vascular tone. Acta Oncol., 34: 373-377, 1995.
30. Cabrera, C., and Bohr, D. The role of nitric oxide in the central control of blood pressure. Biochem, Biophys. Res. Commun,. 206: 77-81, 1995.
31. Schulz, R., and Triggle, C. R. Role of NO in vascular smooth muscle and cardiac muscle function. Trends Pharmacol. Sci., 15: 255-259, 1994.
32. Hori, K., Zhang, Q-H., Saito. S., Tanda, S., Li, H-C., and Suzuki. M, Microvascular mechanisms of change in tumor blood flow due to angiotensin II, epinephrine, and methoxamine: a functional morphometric study, Cancer Res., 53: 5528-5534, 1993.
33. Kubes, P., Suzuki, M., and Granger, D. N. Nitric oxide: an endogenous modulator of leukocyte adhesion, Proc. Natl. Acad. Sci. USA, 88: 4651-4655, 1991.
34. Moncada, S., Palmer, R. M., and Higgs, E. A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43: 109-142, 1991.
35. Southan, G. J., and Szabó, C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem, Pharmacol., 51: 383-394, 1996.
36. Akaike, T., and Maeda, H. Direct quantitation of nitric oxide released from cells using liposome-encapsulated PTIO. In: S, Moncada, J. Stamler, S. Gross, and E. A. Higgs teds.), The Biology of Nitric Oxide, p. 171. London: Portland Press, 1996.
37. Tsunoda, R., Okumura, K., Ishizaka, H., Matsunaga, T., Tabuchi, T., Yasue, H., Akaike, T., Sato, K., and Maeda, H. Vasodilator effect of carboxy-2-phenyl-4,4,5,5 tetramethylimidazoline-1-oxyl in the coronary circulation: in vivo and in vitro studies. Eur. J. Pharmacol., 262: 55-63, 1994.
38. Feelisch, M., te Poel, M., Zamora, R., Deussen, A., and Moncada, S. Understanding the controversy over the identity of EDRF. Nature (Lond.), 368: 62-65, 1994.
39. Kennovin, G. D., Hirst, D. G., Stratford, M. R. L., and Flitney, F. W. Inducible nitric oxide synthase is expressed in tumor-associated vasculature: inhibition retards tumor growth in vivo. In: S. Moncada, M. Feelisch, R. Busse, and E, A. Higgs (eds.), The Biology of Nitric Oxide. 4. Enzymology, Biochemistry and Immunology, pp. 473-479. London: Portland Press, 1994.
40. G-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumor growth in adenocarcinoma-bearing mice. Br. J. Cancer, 73: 189-196, 1996.
41. Rosbe, K, W., Prazma, J., Petrusz, P., Mims, W., Ball, S. S., and Weissler, M. C. Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Otolaryngol. Head Neck Surg., 113: 541-549, 1995.
42. Bastian, N. R., Yim. C-Y., Hibbs, J. B. J., and Samlowski, W. E. Induction of iron-derived EPR signals in murine cancers by nitric oxide. Evidence for multiple intracellular targets. J. Biol. Chem., 269: 5127-5131, 1994.
43. Doi, K., Akaike, T., Horie, H., Noguchi, Y., Fujii, S., Beppu, T., Ogawa, M., and Maeda, H. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth, Cancer (Phila.), 77: 1598-1604, 1996.
44. Thomsen, L. L., Miles, D. W., Happeifield, L., Riveros-Moreno, V., Bobrow, L. G., Knowles, R, G., and Moncada, S, Nitric oxide synthase in human breast cancer tissue is localized within macrophages. In: S. Moncada, M. Feelisch. R. Busse, and E. A. Higgs (eds.), The Biology of Nitric Oxide. 4. Enzymology, Biochemistry and Immunology, pp. 463-466, London: Portland Press, 1994.